BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8728558)

  • 1. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat.
    González MI; Albonetti E; Siddiqui A; Farabollini F; Wilson CA
    Pharmacol Biochem Behav; 1996 May; 54(1):195-203. PubMed ID: 8728558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between 5-hydroxytryptamine (5-HT) and testosterone in the control of sexual and nonsexual behaviour in male and female rats.
    Gonzalez MI; Farabollini F; Albonetti E; Wilson CA
    Pharmacol Biochem Behav; 1994 Mar; 47(3):591-601. PubMed ID: 8208779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the 5-HT1A subtype receptor in the neonatal organization of agonistic behaviour in the rat.
    Albonetti E; González MI; Siddiqui A; Wilson CA; Farabollini F
    Pharmacol Biochem Behav; 1996 May; 54(1):189-93. PubMed ID: 8728557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C; Mørk A
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster.
    Richter A; Löscher W
    Pharmacol Biochem Behav; 1995 Dec; 52(4):655-65. PubMed ID: 8587901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
    Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
    Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.
    Kulikov AV; Kolpakov VG; Maslova GB; Kozintsev I; Popova NK
    Psychopharmacology (Berl); 1994 Feb; 114(1):172-4. PubMed ID: 7846200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH; Broekkamp CL
    Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
    Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats.
    Ellenbroek BA; Prinssen EP; Cools AR
    Eur J Neurosci; 1994 Jan; 6(1):1-8. PubMed ID: 7907518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.